Bluejay Diagnostics Inc (BJDX): Analyst Forecast Prices

Bluejay Diagnostics (BJDX) is currently undergoing the certification phase for its products, meaning the business relies on investments rather than a stable cash flow. The developer of rapid sepsis testing systems creates immense value for intensive care specialists, enabling the implementation of premium pricing. This price chart on GURU.Markets, where the consensus stands at 205586.23, confirms the company's significant pricing power driven by its unique Symphony platform.

BJDX (Bluejay Diagnostics Inc) Consensus Target history from 07/04/2022 to 11/11/2026

Analytical breakdowns for Bluejay (BJDX)

- current price and projected stock value:

Price Chart bluejaydx.com|BJDX - Price Target Chart

- stock exchange capitalization data:

Market Value Bluejay|BJDX - Enterprise Value

- book capitalization information:

Equity per Share Bluejay Diagnostics|BJDX - Company Net Assets|Capitalization to Book Value Ratio bluejaydx.com|BJDX - Aggregate Company Assets

- debt obligations and liquidity statistics:

- net income and valuation multiples indicators:

BJDX - Net Profit|Projected Future Earnings Bluejay Diagnostics|BJDX - Price to Earnings Ratio|Future Price to Earnings Bluejay Diagnostics Inc|BJDX - Price/Earnings to Growth Multiple|Company Value to EBITDA Bluejay|BJDX - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Bluejay Diagnostics|BJDX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months bluejaydx.com|BJDX - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year Bluejay Diagnostics

General company analysis:bluejaydx.com (BJDX)

Original product of Bluejay Diagnostics, Inc.

The price action of the average fair value estimate for Bluejay Diagnostics (BJDX) reflects expert reactions to geopolitical barriers restricting the export of sepsis tests and equipment procurement. This indicator synthesizes analyst opinions into a single price benchmark, allowing investors to determine the synchronicity of market expectations through the analysis of this average valuation and timely recognize a shift in the asset's fundamental value trend.

Competing companies